Cetaphil® Skin Care Products
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Class-Action Tracker
The Latest
CFPB Proposes Paycheck Advance Rule
TINA.org joins coalition of consumer organizations in support of the proposed rule
ARMRA Colostrum Supplements
Company distances itself from touted “studies” while continuing to use deceptive health claims.
Amazon $700 Weekly Vehicle Advertisement Program
Can you earn a salary just by placing a small sticker on your car?
CATrends: Fish Oil Supplements Marketed to Support Heart Health
Lawsuits accuse companies of using deceptive claims to reel in consumers.
Huel
U.K. ad regulator takes issue with celeb endorsement.